Skip to main content

Table 1 Characteristics and medical history at enrollment (3 months after COVID-19 symptoms onset)

From: Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

  Patients (n = 85)
Age, years 68.4 (60.1–72.9)
Male 67 (78.8%)
Smoking status  
 Current smoker 1 (1.2%)
 Former smoker 49 (57.6%)
 Never smoker 35 (41.2%)
Comorbidities before SARS-CoV-2 infection  
 Obesity 28 (32.9%)
  Class I (BMI 30–34.9) 15 (53.6%)
  Class II (BMI 35–39.9) 10 (35.7%)
  Class III (BMI ≥ 40) 3 (10.7%)
 Cardiovascular  
  Ischemic heart disease 9 (10.6%)
  Heart failure 1 (1.2%)
  Atrial fibrillation 7 (8.2%)
  Stroke 2 (2.4%)
 Respiratory diseases  
  COPD 7 (8.2%)
  Asthma 6 (7.1%)
  Sleep apnea 16 (18.8%)
 Other cardiovascular risk factors  
  Hypertension 44 (51.8%)
  Diabetes 21 (24.7%)
  Dyslipidemia 27 (31.8%)
 Thromboembolic disease  
  Deep vein thrombosis 4 (4.7%)
  Pulmonary embolism 0 (0.0%)
Intensive care unit  
 Length of stay (days) 17 (11.0–26.5)
 Intubation 73 (85.9%)
 Neuromuscular blocking agents (N = 72)a 71 (98.6%)
 High flow oxygen therapyb 35 (41.2%)
  Before intubation 14 (16.5%)
  After intubation 29 (41.4%)
 Non-invasive ventilationb 12 (14.1%)
  Before intubation 1 (1.2%)
  After intubation 10 (14.1%)
 Prone position 62 (73.8%)
 Pulmonary embolism 20 (23.5%)
Hospital stay  
 Length of hospitalization (days) 45 (20–62)
 In-hospital COVID-directed treatments  
  Corticosteroids 36 (42.4%)
  Remdisivir 5 (5.9%)
  Lopinavir 9 (10.6%)
  Ritonavir 10 (11.8%)
  Hydroxychloroquine 54 (63.5%)
  Azithromycin 45 (52.9%)
  Others macrolides 55 (64.7%)
Rehabilitation post hospitalization  
 Admission in rehabilitation units 57 (67.1%)
 Return home with rehabilitation 11 (12.9%)
 Return home without rehabilitation 17 (20.0%)
  1. Values are presented as medians (interquartile ranges) or number of patients (percentages)
  2. BMI body mass index, COPD chronic obstructive pulmonary disease
  3. aData were unavailable for 1 the 73 intubate patients
  4. bDetails were missing for 2 patients in high-flow oxygen therapy and 1 for non-invasive ventilation